Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera

  1. Berenbaum, F.
  2. Blanco, F.J.
  3. Guermazi, A.
  4. Miki, K.
  5. Yamabe, T.
  6. Viktrup, L.
  7. Junor, R.
  8. Carey, W.
  9. Brown, M.T.
  10. West, C.R.
  11. Verburg, K.M.
Journal:
Annals of the Rheumatic Diseases

ISSN: 1468-2060 0003-4967

Year of publication: 2022

Volume: 81

Issue: 4

Pages: E66

Type: Letter

DOI: 10.1136/ANNRHEUMDIS-2020-217629 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals